Bayer Corporation Sells High-Performance Organic Pigment Business to Sun Chemical Corporation

    PITTSBURGH, Feb. 6 -- Bayer Corporation today
announced the sale of Bayer Polymers LLC's high-performance organic pigment
business to Sun Chemical Corporation.
    The sale, which includes the high-performance organic pigment
manufacturing and wastewater treatment facilities at Bayer's Bushy Park site
in South Carolina, was completed on Jan. 31.  Terms were not disclosed.
    The high-performance organic pigment products acquired by Sun Chemical in
the acquisition are used in automotive coatings, industrial and architectural
coatings, as well as plastics, fabric and fiber coloring.  The products
include Indofast(R) carbazole violet, Perrindo(R) perylene, Quindo(R)
quinacridone and Palomar(R) pthalocyanine pigments.  Approximately 140 Bayer
employees will be transferred to Sun Chemical's Performance Pigments Group.
    Bayer will continue to produce and market other colorants including
Macrolex(R) dyes, Pigment Yellow 150 and Bayferrox(R) iron oxide pigments.
Bayer's organic pigments produced in Lerma, Mexico, and Leverkusen, Germany,
are also not included in the sale.
    At the Bushy Park facility, located 25 miles northeast of Charleston,
S.C., Bayer produces dyestuffs and specialty colorants for the textile and
paper industries; organic intermediates; and Dorlastan(R) spandex fibers used
in the sportswear and textile industries.
    Sun Chemical will become the third non-Bayer tenant at the Bushy Park
site.  Other companies with operations there include Haarmann & Reimer, a New
Jersey general partnership which produces synthetic menthols for flavorings
and personal care products, aroma esters used in perfumes and sunscreen agents
for cosmetics, and Agfa Corporation, which produces photographic film
products.
    Headquartered in Pittsburgh, Bayer Corporation had sales of $10.1 billion
in 2001 and is one of Fortune magazine's Most Admired Companies.  The company
employs 21,500 people.  It is a member of the worldwide Bayer Group, a
$27 billion international health care and chemicals group based in Leverkusen,
Germany.  Bayer's four operating companies -- CropScience, Chemicals,
HealthCare and Polymers -- produce a broad range of products that help
diagnose and treat diseases, purify water, preserve local landmarks, protect
crops, advance automobile safety and durability and improve people's lives.
    The Bayer Group has nearly 128,000 employees.  Its stock is a component of
the DAX and is listed on the New York Stock Exchange .  For 2001,
the group recorded sales of EUR 30.3 billion and a group net profit of
EUR 965 million.  Capital expenditures totaled EUR 2.6 billion, and
EUR 2.6 billion was invested in research and development.

    This news release contains forward-looking statements based on current
assumptions and forecasts made by Bayer Group management.  Various known and
unknown risks, uncertainties and other factors could lead to material
differences between the actual future results, financial situation,
development or performance of the company and the estimates given here.  These
factors include those discussed in our public reports filed with the Frankfurt
Stock Exchange and with the U.S. Securities and Exchange Commission (including
our Form 20-F).  The company assumes no liability whatsoever to update these
forward-looking statements or to conform them to future events or
developments.